基于钆塞酸增强MRI深度学习分析全自动预测肝纤维化
单中心回顾性研究纳入355例有病理对照的患者,用钆塞酸增强肝胆期MRI构建全自动深度学习模型预测肝纤维化分期,并在测试集与MR弹性成像比较。深度学习在各期AUC为0.77~0.91,与MR弹性成像无显著差异(p>0.134),结论认为经独立验证后该算法可在无需额外MRI硬件的条件下无创评估肝纤维化。
要点
- 深度学习模型基于常规钆塞酸增强肝胆期MRI,自动分割肝脏后预测纤维化分期F1-4至F4。
- 测试集深度学习AUC为F1-4 0.77、F2-4 0.91、F3-4 0.90、F4 0.85。
- 测试集MR弹性成像AUC为F1-4 0.86、F2-4 0.87、F3-4 0.92、F4 0.86,与深度学习无显著差异。
核心结论
- 基于钆塞酸增强肝胆期MRI的全自动深度学习模型对肝纤维化分期具有良好至优秀的诊断性能,与MR弹性成像诊断性能相似。
- 作者认为该深度学习算法经独立数据集验证后,可能实现无需额外MRI硬件的无创肝纤维化评估。
研究设计与样本
- 单中心回顾性研究纳入355例患者(男/女238/117,平均年龄60岁),均在MRI前1年内接受肝脏病理评估。
- 数据集分为训练集178例、验证集123例、测试集54例。
- 输入为全自动肝脏分割后裁剪的肝胆期图像,采用基于ImageNet VGG16模型的迁移学习方法。
- 针对纤维化分期F1-4、F2-4、F3-4和F4分别构建不同深度学习模型。
- 以受试者工作特征曲线分析评估深度学习在训练集、验证集和测试集的性能,以及测试集中MR弹性成像肝脏硬度的性能。
诊断标准与关键数值
- 深度学习AUC在训练集/验证集/测试集分别为:F1-4 0.99/0.70/0.77,F2-4 0.92/0.71/0.91,F3-4 0.91/0.78/0.90,F4 0.98/0.83/0.85。
- 测试集MR弹性成像肝脏硬度AUC为:F1-4 0.86,F2-4 0.87,F3-4 0.92,F4 0.86。
- MR弹性成像与深度学习在各纤维化分期的AUC均无显著差异(p>0.134)。
临床应用与阅片要点
- 深度学习模型可直接基于常规钆塞酸增强肝胆期MRI数据运行,无需额外MRI硬件即可输出肝纤维化分期预测。
- 研究中深度学习与MR弹性成像诊断性能相似,但原文结论指出该算法尚需在独立数据集验证。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: To (1) develop a fully automated deep learning (DL) algorithm based on gadoxetic acid-enhanced hepatobiliary phase (HBP) MRI and (2) compare the diagnostic performance of DL vs. MR elastography (MRE) for noninvasive staging of liver fibrosis.
METHODS: This single-center retrospective study included 355 patients (M/F 238/117, mean age 60 years; training, n = 178; validation, n = 123; test, n = 54) who underwent gadoxetic acid-enhanced abdominal MRI, including HBP and MRE, and pathological evaluation of the liver within 1 year of MRI. Cropped liver HBP images from a custom-written fully automated liver segmentation were used as input for DL. A transfer learning approach based on the ImageNet VGG16 model was used. Different DL models were built for the prediction of fibrosis stages F1-4, F2-4, F3-4, and F4. ROC analysis was performed to evaluate the performance of DL in training, validation, and test sets and of MRE liver stiffness in the test set.
RESULTS: AUC values of DL were 0.99/0.70/0.77 (F1-4), 0.92/0.71/0.91 (F2-4), 0.91/0.78/0.90 (F3-4), and 0.98/0.83/0.85 (F4) for training/validation/test sets, respectively. The AUCs of MRE liver stiffness in the test set were 0.86 (F1-4), 0.87 (F2-4), 0.92 (F3-4), and 0.86 (F4). AUCs of MRE and DL were not significantly different for any of the fibrosis stages (p > 0.134).
CONCLUSIONS: The fully automated DL models based on HBP gadoxetic acid MRI showed good-to-excellent diagnostic performance for staging of liver fibrosis, with similar diagnostic performance to MRE. After validation in independent sets, the DL algorithm may allow for noninvasive liver fibrosis assessment without the need for additional MRI hardware.
KEY POINTS: • The developed deep learning algorithm, based on routine standard-of-care gadoxetic acid-enhanced MRI data, showed good-to-excellent diagnostic performance for noninvasive staging of liver fibrosis. • The diagnostic performance of the deep learning algorithm was equivalent to that of MR elastography in a separate test set.
引用
- Hectors SJ, Kennedy P, Huang KH, et al. Fully automated prediction of liver fibrosis using deep learning analysis of gadoxetic acid-enhanced MRI. Eur Radiol. 2020. PMID: 33201285. doi:10.1007/s00330-020-07475-4
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。